Bruce Van Saun appointed CEO of Citizens Bank
The Royal Bank of Scotland named Bruce Van Saun chief executive of RBS Citizens Financial Group Inc. as the British lender prepares to sell a stake in the U.S. division.
Van Saun, finance director of RBS, will replace Ellen Alemany, who is retiring after more than six years at the Rhode Island-based bank. Nathan Bostock, RBS's chief risk officer, will replace Van Saun. The appointments will take effect on Oct. 1.
Citizens Bank — the Pittsburgh region's second-largest retail bank, with 132 branches — is part of RBS Citizens Financial Group in Providence, R.I., which is Royal Bank of Scotland's banking franchise in the United States.
Van Saun joined RBS in 2009 after serving as Bank of New York Mellon Corp.'s chief financial officer. He left BNY Mellon in July 2008 after helping merge the Bank of New York and Mellon Financial Corp. Citizens entered Pennsylvania with its 2001 acquisition of Mellon's retail bank.
Van Saun joined RBS after the bank received $70.6 billion in the biggest banking bailout in the world in 2008 and 2009. RBS has since shrunk the bank's balance sheet by more than $1.4 billion.
Alemany became CEO of Citizens in 2008 after the resignation of Steve Steinour, now CEO of Huntington Bancshares.
RBS CEO Stephen Hester said Van Saun, 55, who is originally from New Jersey, will lead Citizens in the run-up to the anticipated initial public offering.
Britain's biggest government-owned bank said in February it plans to sell a 25 percent stake in Citizens in the next two years after coming under pressure from regulators to boost capital.
Bloomberg and the Associated Press contributed to this story.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Stocks finish weak before Thanksgiving holiday; energy firms give back some gains
- Union leaders warn Post-Gazette newsroom of possible layoffs
- Covestro leader MacCleary finds stability amid change
- Black Friday loosens its hold on the holiday season
- Pa. PUC looks to update safety rules for electric utilities
- Mall stores required to open for Thanksgiving
- Improving economy challenges retailers seeking to boost ranks for holidays
- ‘Word people’ could start careers as court reporters, medical scribes
- Pfizer acquires Allergan in $160B deal
- Feds upgrade GDP’s growth
- German financial giant Allianz SE slashes coal investments